Onyx Biotec Limited
✓Strengths
- Low debt: debt-to-equity of 0.27.
- Promoters hold a majority stake (65.1%).
!Watch-points
- Return on equity is on the lower side at -0.4%.
- Return on capital employed is on the lower side at 1.1%.
- The company reported a net loss in the latest period.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
1.83
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreWeak
1 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 69 Cr
Current Price—
High / Low₹ 50.00 / 24.20
Stock P/E—
Book Value₹ 30.60
Dividend Yield0.00%
ROCE1.14%
ROE-0.38%
Face Value₹ 10.00
Debt to Equity0.27
PEG Ratio—
EV / EBITDA13.03
Industry PE35.70
P/B Ratio—
EPS₹ -0.12
Debt₹ 15 Cr
PAT Margin-0.30%
Cash PAT₹ 3 Cr
ICR2.81
Promoter Holding65.10%
FII Holding1.07%
DII Holding2.39%
Public Holding31.44%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity